ScaleIQ is an AI-driven health technology company redefining how clinical research is conducted and understood. We combine advanced analytics, digital retina features, biomarkers, and real-world data to create a unified, longitudinal view of patient health. Our platform enables earlier detection of safety signals, more precise monitoring of systemic toxicity, and improved understanding of disease progression and treatment response.
By connecting clinical trial data with real-world evidence, ScaleIQ moves beyond static snapshots to continuous, data-driven insight—improving development efficiency, predicting outcomes, and ultimately delivering better results for patients. Our long-term vision is to fundamentally change how disease progression and treatment safety are measured, and to accelerate breakthroughs in areas of highest unmet need, including neurodegenerative diseases and oncology.
